Abstract | PURPOSE: To investigate the differences in natural course, intravitreal bevacizumab injection (IVB) responsiveness, and optical coherence tomography angiography findings according to the type of pigment epithelial detachment (PED) in patients with central serous chorioretinopathy (CSC). METHODS: A retrospective review of angiographically proven CSC patients was conducted. Pigment epithelium detachment was classified as flat irregular or focal. To identify the natural course of CSC, we had observed whether subretinal fluid was improved without any treatment until symptom duration was >3 months. When CSC symptom duration was >3 months, IVB injection was performed. Symptom duration, central subfield thickness, subfoveal choroidal thickness, presence of subretinal fluid, natural course, optical coherence tomography angiography findings, and IVB responsiveness were compared between the PED types. RESULTS: One hundred eyes were included (64 flat irregular PED vs. 34 focal PED). Flat irregular PED had a longer symptom duration than focal PED (7.20 ± 11.52 vs. 3.69 ± 3.98 months, P = 0.03). In untreated cases, the rate of complete resolution of subretinal fluid was significantly lower in flat irregular PED than in focal PED (34.78% vs. 65.22%, P = 0.017). In contrast to the natural course, responsiveness to IVB was significantly better in flat irregular PED (72.41% vs. 31.58%, P = 0.005). Optical coherence tomography angiography revealed more CNV in flat irregular PED (42.90% vs. 10.00%, P = 0.014). Subfoveal choroidal thickness in flat irregular PED was significantly thicker. CONCLUSION: In CSC patients with flat irregular PED, the natural course was poor, but treatment response to IVB was favorable. Flat irregular PED patients showed longer symptom duration and thicker subfoveal choroidal thickness than those with focal PED. Optical coherence tomography angiography revealed more choroidal neovascularization in flat irregular PED. These findings suggest that CSC with flat irregular PED could be considered a form of pachychoroid neovasculopathy.
|
Authors | Hyeseong Hwang, Jin Young Kim, Kyung Tae Kim, Ju Byung Chae, Dong Yoon Kim |
Journal | Retina (Philadelphia, Pa.)
(Retina)
Vol. 40
Issue 9
Pg. 1724-1733
(Sep 2020)
ISSN: 1539-2864 [Electronic] United States |
PMID | 31584559
(Publication Type: Journal Article)
|
Chemical References |
- Angiogenesis Inhibitors
- Coloring Agents
- VEGFA protein, human
- Vascular Endothelial Growth Factor A
- Bevacizumab
- Indocyanine Green
|
Topics |
- Adult
- Angiogenesis Inhibitors
(therapeutic use)
- Bevacizumab
(therapeutic use)
- Central Serous Chorioretinopathy
(diagnosis, drug therapy, physiopathology)
- Choroidal Neovascularization
(diagnosis, drug therapy, physiopathology)
- Coloring Agents
(administration & dosage)
- Female
- Fluorescein Angiography
- Humans
- Indocyanine Green
(administration & dosage)
- Intravitreal Injections
- Male
- Middle Aged
- Retinal Detachment
(diagnosis, physiopathology)
- Retinal Pigment Epithelium
(pathology)
- Retrospective Studies
- Subretinal Fluid
- Tomography, Optical Coherence
- Vascular Endothelial Growth Factor A
(antagonists & inhibitors)
- Visual Acuity
(physiology)
|